Chemours Co

CCReported to SECin USCIK 0001627223Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 15. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 15
Form 4 lines at Chemours Co, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
MATHER COURTNEY—Award$28,7412,118 sharesOct 1, 2026MATHER COURTNEY$28,741Award · Oct 1Award2,118Oct 1, 2026
Will DavidChief Accounting OfficerAdministrative$36,9722,426 sharesAug 13, 2026Will DavidChief Accounting Officer$36,972Admin · Aug 13Administrative2,426Aug 13, 2026
Familiar Calderon GerardoSee RemarksOpen-market buy$30,0511,935 sharesAug 13, 2026Familiar Calderon GerardoSee Remarks$30,051Buy · Aug 13Open-market buy1,935Aug 13, 2026
Dignam DeniseChief Executive OfficerOpen-market buy$50,5013,378 sharesAug 13, 2026Dignam DeniseChief Executive Officer$50,501Buy · Aug 13Open-market buy3,378Aug 13, 2026
Cowan Alister—Open-market buy$203,06013,000 sharesAug 11, 2026Cowan Alister$203,060Buy · Aug 11Open-market buy13,000Aug 11, 2026